

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | nuclear pore complex assembly (GO:0051292) | 4.90718201 |
| 2 | regulation of RNA export from nucleus (GO:0046831) | 4.26573667 |
| 3 | desmosome organization (GO:0002934) | 4.25261409 |
| 4 | nuclear pore organization (GO:0006999) | 4.16280331 |
| 5 | lysine catabolic process (GO:0006554) | 3.97311710 |
| 6 | lysine metabolic process (GO:0006553) | 3.97311710 |
| 7 | regulation of nucleobase-containing compound transport (GO:0032239) | 3.95557276 |
| 8 | L-phenylalanine catabolic process (GO:0006559) | 3.88022761 |
| 9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.88022761 |
| 10 | alpha-linolenic acid metabolic process (GO:0036109) | 3.87212200 |
| 11 | carnitine shuttle (GO:0006853) | 3.76582305 |
| 12 | fatty acid transmembrane transport (GO:1902001) | 3.68609767 |
| 13 | vesicle coating (GO:0006901) | 3.68564124 |
| 14 | histone H3-K36 demethylation (GO:0070544) | 3.66640059 |
| 15 | 2-oxoglutarate metabolic process (GO:0006103) | 3.63212856 |
| 16 | mitotic chromosome condensation (GO:0007076) | 3.62565988 |
| 17 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.62551350 |
| 18 | L-phenylalanine metabolic process (GO:0006558) | 3.62551350 |
| 19 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.47425999 |
| 20 | mitotic sister chromatid cohesion (GO:0007064) | 3.40996504 |
| 21 | Golgi transport vesicle coating (GO:0048200) | 3.39967431 |
| 22 | COPI coating of Golgi vesicle (GO:0048205) | 3.39967431 |
| 23 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.38776896 |
| 24 | pore complex assembly (GO:0046931) | 3.31697846 |
| 25 | aspartate family amino acid catabolic process (GO:0009068) | 3.30327246 |
| 26 | regulation of NFAT protein import into nucleus (GO:0051532) | 3.29851047 |
| 27 | regulation of cholesterol homeostasis (GO:2000188) | 3.29274220 |
| 28 | 4-hydroxyproline metabolic process (GO:0019471) | 3.28189938 |
| 29 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.27018824 |
| 30 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.26614238 |
| 31 | protein carboxylation (GO:0018214) | 3.22807734 |
| 32 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.22807734 |
| 33 | hemidesmosome assembly (GO:0031581) | 3.22521433 |
| 34 | histone H3-K9 demethylation (GO:0033169) | 3.21336949 |
| 35 | regulation of early endosome to late endosome transport (GO:2000641) | 3.20679839 |
| 36 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.19272964 |
| 37 | sulfur amino acid catabolic process (GO:0000098) | 3.17068314 |
| 38 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.16514125 |
| 39 | phospholipid homeostasis (GO:0055091) | 3.16412415 |
| 40 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.16341778 |
| 41 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.15742703 |
| 42 | fatty acid beta-oxidation (GO:0006635) | 3.13485459 |
| 43 | kynurenine metabolic process (GO:0070189) | 3.12075345 |
| 44 | tricarboxylic acid metabolic process (GO:0072350) | 3.11414995 |
| 45 | aromatic amino acid family catabolic process (GO:0009074) | 3.10629987 |
| 46 | plasma membrane repair (GO:0001778) | 3.09905895 |
| 47 | glyoxylate metabolic process (GO:0046487) | 3.08779572 |
| 48 | regulation of triglyceride catabolic process (GO:0010896) | 3.06333349 |
| 49 | cell-substrate junction assembly (GO:0007044) | 3.00678075 |
| 50 | cell-substrate adherens junction assembly (GO:0007045) | 2.99897680 |
| 51 | focal adhesion assembly (GO:0048041) | 2.99897680 |
| 52 | skin morphogenesis (GO:0043589) | 2.99804931 |
| 53 | valine metabolic process (GO:0006573) | 2.98690250 |
| 54 | sarcomere organization (GO:0045214) | 2.98599652 |
| 55 | adherens junction assembly (GO:0034333) | 2.97732962 |
| 56 | embryonic process involved in female pregnancy (GO:0060136) | 2.97670793 |
| 57 | regulation of fatty acid oxidation (GO:0046320) | 2.97254172 |
| 58 | positive regulation of lipid catabolic process (GO:0050996) | 2.93537285 |
| 59 | cysteine metabolic process (GO:0006534) | 2.93015925 |
| 60 | negative regulation of fibrinolysis (GO:0051918) | 2.92877570 |
| 61 | COPII vesicle coating (GO:0048208) | 2.92370514 |
| 62 | fatty acid oxidation (GO:0019395) | 2.91977208 |
| 63 | protein localization to endosome (GO:0036010) | 2.91384566 |
| 64 | urea metabolic process (GO:0019627) | 2.91326958 |
| 65 | urea cycle (GO:0000050) | 2.91326958 |
| 66 | positive regulation of fatty acid oxidation (GO:0046321) | 2.91219717 |
| 67 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.90565416 |
| 68 | carnitine transmembrane transport (GO:1902603) | 2.89313938 |
| 69 | complement activation, alternative pathway (GO:0006957) | 2.88890060 |
| 70 | acetyl-CoA metabolic process (GO:0006084) | 2.88366248 |
| 71 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.87789823 |
| 72 | epithelial cell-cell adhesion (GO:0090136) | 2.87591857 |
| 73 | lipid oxidation (GO:0034440) | 2.83766079 |
| 74 | amino-acid betaine metabolic process (GO:0006577) | 2.83537689 |
| 75 | amino-acid betaine transport (GO:0015838) | 2.83280116 |
| 76 | carnitine transport (GO:0015879) | 2.83280116 |
| 77 | fatty acid catabolic process (GO:0009062) | 2.82853846 |
| 78 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.82000094 |
| 79 | protein localization to microtubule (GO:0035372) | 2.81143858 |
| 80 | positive regulation of histone deacetylation (GO:0031065) | 2.79577760 |
| 81 | plasma lipoprotein particle clearance (GO:0034381) | 2.79556731 |
| 82 | short-chain fatty acid metabolic process (GO:0046459) | 2.78712651 |
| 83 | low-density lipoprotein particle clearance (GO:0034383) | 2.75055701 |
| 84 | cardiac myofibril assembly (GO:0055003) | 2.74711820 |
| 85 | glutamate metabolic process (GO:0006536) | 2.74323210 |
| 86 | growth hormone receptor signaling pathway (GO:0060396) | 2.72695459 |
| 87 | histone lysine demethylation (GO:0070076) | 2.72089447 |
| 88 | positive regulation of nuclease activity (GO:0032075) | 2.72049308 |
| 89 | regulation of protein activation cascade (GO:2000257) | 2.69766661 |
| 90 | high-density lipoprotein particle remodeling (GO:0034375) | 2.69631878 |
| 91 | cellular modified amino acid catabolic process (GO:0042219) | 2.68900055 |
| 92 | proline biosynthetic process (GO:0006561) | 2.68380533 |
| 93 | bile acid biosynthetic process (GO:0006699) | 2.68181482 |
| 94 | monocarboxylic acid catabolic process (GO:0072329) | 2.67019996 |
| 95 | cellular ketone body metabolic process (GO:0046950) | 2.66312416 |
| 96 | positive regulation of glycolytic process (GO:0045821) | 2.65196398 |
| 97 | activation of Rac GTPase activity (GO:0032863) | 2.65140813 |
| 98 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.64075181 |
| 99 | creatine metabolic process (GO:0006600) | 2.62875373 |
| 100 | positive regulation of transcription from RNA polymerase III promoter (GO:0045945) | 2.62219485 |
| 101 | histone demethylation (GO:0016577) | 2.61833209 |
| 102 | regulation of sequestering of triglyceride (GO:0010889) | 2.61653654 |
| 103 | oxaloacetate metabolic process (GO:0006107) | 2.61280933 |
| 104 | protein retention in ER lumen (GO:0006621) | 2.61157401 |
| 105 | intracellular lipid transport (GO:0032365) | 2.61100328 |
| 106 | homocysteine metabolic process (GO:0050667) | 2.59605495 |
| 107 | nitrogen cycle metabolic process (GO:0071941) | 2.58691559 |
| 108 | iron ion import (GO:0097286) | 2.58521866 |
| 109 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.57738725 |
| 110 | hypotonic response (GO:0006971) | 2.56627088 |
| 111 | regulation of complement activation (GO:0030449) | 2.56123787 |
| 112 | hormone catabolic process (GO:0042447) | 2.55758117 |
| 113 | ethanol oxidation (GO:0006069) | 2.55342912 |
| 114 | intestinal cholesterol absorption (GO:0030299) | 2.54826124 |
| 115 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.54591354 |
| 116 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.53946085 |
| 117 | reverse cholesterol transport (GO:0043691) | 2.53685868 |
| 118 | macroautophagy (GO:0016236) | 2.53042959 |
| 119 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.51161889 |
| 120 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.51050700 |
| 121 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.50900622 |
| 122 | carnitine metabolic process (GO:0009437) | 2.50764599 |
| 123 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.50583211 |
| 124 | negative regulation of sterol transport (GO:0032372) | 2.49115271 |
| 125 | negative regulation of cholesterol transport (GO:0032375) | 2.49115271 |
| 126 | cell adhesion mediated by integrin (GO:0033627) | 2.48403096 |
| 127 | regulation of fibrinolysis (GO:0051917) | 2.47565268 |
| 128 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.47389774 |
| 129 | regulation of histone H3-K27 methylation (GO:0061085) | 2.47354809 |
| 130 | tryptophan catabolic process (GO:0006569) | 2.46912325 |
| 131 | indole-containing compound catabolic process (GO:0042436) | 2.46912325 |
| 132 | indolalkylamine catabolic process (GO:0046218) | 2.46912325 |
| 133 | cellular response to unfolded protein (GO:0034620) | 2.46817027 |
| 134 | protein export from nucleus (GO:0006611) | 2.46371681 |
| 135 | peptidyl-lysine dimethylation (GO:0018027) | 2.45956645 |
| 136 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.45667119 |
| 137 | tricarboxylic acid cycle (GO:0006099) | 2.45594772 |
| 138 | regulation of nuclease activity (GO:0032069) | 2.45422577 |
| 139 | drug transmembrane transport (GO:0006855) | 2.45209665 |
| 140 | bile acid metabolic process (GO:0008206) | 2.44572288 |
| 141 | peptidyl-threonine modification (GO:0018210) | 2.44387918 |
| 142 | regulation of water loss via skin (GO:0033561) | 2.44327589 |
| 143 | ER-nucleus signaling pathway (GO:0006984) | 2.44140196 |
| 144 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.43291612 |
| 145 | ER overload response (GO:0006983) | 2.42337455 |
| 146 | negative regulation of cell size (GO:0045792) | 2.41531721 |
| 147 | regulation of translational fidelity (GO:0006450) | 2.40143705 |
| 148 | protein hydroxylation (GO:0018126) | 2.39199138 |
| 149 | stress fiber assembly (GO:0043149) | 2.38440655 |
| 150 | nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289) | 2.34173444 |
| 151 | mRNA stabilization (GO:0048255) | 2.33980241 |
| 152 | RNA stabilization (GO:0043489) | 2.33980241 |
| 153 | cellular protein complex localization (GO:0034629) | 2.33445682 |
| 154 | positive regulation of p38MAPK cascade (GO:1900745) | 2.33228167 |
| 155 | positive regulation of macroautophagy (GO:0016239) | 2.32585787 |
| 156 | peptidyl-proline hydroxylation (GO:0019511) | 2.30877134 |
| 157 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.30624661 |
| 158 | protein dealkylation (GO:0008214) | 2.29353676 |
| 159 | protein demethylation (GO:0006482) | 2.29353676 |
| 160 | peptidyl-threonine phosphorylation (GO:0018107) | 2.29141585 |
| 161 | paraxial mesoderm development (GO:0048339) | 2.28124152 |
| 162 | negative regulation of fatty acid transport (GO:2000192) | 2.27299211 |
| 163 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.25856394 |
| 164 | NADH metabolic process (GO:0006734) | 2.25512393 |
| 165 | mammary gland epithelial cell proliferation (GO:0033598) | 2.25205801 |
| 166 | hippo signaling (GO:0035329) | 2.24302638 |
| 167 | DNA synthesis involved in DNA repair (GO:0000731) | 2.24139406 |
| 168 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 2.23032385 |
| 169 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.22180477 |
| 170 | negative regulation of histone methylation (GO:0031061) | 2.21910680 |
| 171 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.21770204 |
| 172 | Golgi organization (GO:0007030) | 2.20972220 |
| 173 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.20699905 |
| 174 | cellular response to topologically incorrect protein (GO:0035967) | 2.20585136 |
| 175 | response to epidermal growth factor (GO:0070849) | 2.20405147 |
| 176 | cellular response to epidermal growth factor stimulus (GO:0071364) | 2.19879124 |
| 177 | response to endoplasmic reticulum stress (GO:0034976) | 2.19776636 |
| 178 | negative regulation of DNA repair (GO:0045738) | 2.19502866 |
| 179 | maternal placenta development (GO:0001893) | 2.18217708 |
| 180 | NLS-bearing protein import into nucleus (GO:0006607) | 2.13477652 |
| 181 | negative regulation of anoikis (GO:2000811) | 2.13096315 |
| 182 | surfactant homeostasis (GO:0043129) | 2.09300449 |
| 183 | basement membrane organization (GO:0071711) | 2.09030533 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.65737030 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.17005488 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.80696163 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.76424597 |
| 5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.69746787 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.67382981 |
| 7 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.07455564 |
| 8 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.04142204 |
| 9 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.77341657 |
| 10 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.64966733 |
| 11 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.58852902 |
| 12 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.46741471 |
| 13 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.43847145 |
| 14 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.36735910 |
| 15 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.23978932 |
| 16 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 2.06524336 |
| 17 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.05705445 |
| 18 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.91426266 |
| 19 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.91052889 |
| 20 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.85429588 |
| 21 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.82807003 |
| 22 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.80746960 |
| 23 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.79859021 |
| 24 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.79859021 |
| 25 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.78152050 |
| 26 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.77486318 |
| 27 | MYC_22102868_ChIP-Seq_BL_Human | 1.77312480 |
| 28 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.74880341 |
| 29 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.73321509 |
| 30 | GATA1_22025678_ChIP-Seq_K562_Human | 1.73196244 |
| 31 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.72996943 |
| 32 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.72996943 |
| 33 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.72166891 |
| 34 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.71362070 |
| 35 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.71023896 |
| 36 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.65797155 |
| 37 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.63094524 |
| 38 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.61206132 |
| 39 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.59387209 |
| 40 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.52502356 |
| 41 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.51668381 |
| 42 | GATA1_19941826_ChIP-Seq_K562_Human | 1.46934413 |
| 43 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.45577413 |
| 44 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.45161634 |
| 45 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.42394274 |
| 46 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.39375600 |
| 47 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.39328857 |
| 48 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.37014396 |
| 49 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.36868797 |
| 50 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.36626919 |
| 51 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.35582361 |
| 52 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.32637721 |
| 53 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.32285447 |
| 54 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.32011049 |
| 55 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.32004233 |
| 56 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.30321164 |
| 57 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.29227496 |
| 58 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.27914914 |
| 59 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.27752293 |
| 60 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.27303344 |
| 61 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.27224303 |
| 62 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.26992622 |
| 63 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.26110061 |
| 64 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.25909737 |
| 65 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.25368004 |
| 66 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.24753319 |
| 67 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.24616930 |
| 68 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.23955960 |
| 69 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.21282178 |
| 70 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.20046014 |
| 71 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.19903729 |
| 72 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.19556823 |
| 73 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.19451127 |
| 74 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.19332480 |
| 75 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.18698313 |
| 76 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.18307738 |
| 77 | KDM2B_26808549_Chip-Seq_K562_Human | 1.17695211 |
| 78 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.16927628 |
| 79 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.15992992 |
| 80 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.15576344 |
| 81 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.14978248 |
| 82 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.14356123 |
| 83 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.14353515 |
| 84 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.14209134 |
| 85 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.13731278 |
| 86 | GATA2_19941826_ChIP-Seq_K562_Human | 1.13325910 |
| 87 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.12925598 |
| 88 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.11668979 |
| 89 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.11589224 |
| 90 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.10855092 |
| 91 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.10320943 |
| 92 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.09959714 |
| 93 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.09592703 |
| 94 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.08175829 |
| 95 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.07647691 |
| 96 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.07388677 |
| 97 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.06476013 |
| 98 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.06340509 |
| 99 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.06114370 |
| 100 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.05031377 |
| 101 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.04352470 |
| 102 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.03783308 |
| 103 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.02344094 |
| 104 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.01789419 |
| 105 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.01143112 |
| 106 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.01044226 |
| 107 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.01043071 |
| 108 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.00607957 |
| 109 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.00154546 |
| 110 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.99958290 |
| 111 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.99571841 |
| 112 | * ATF3_27146783_Chip-Seq_COLON_Human | 0.98724174 |
| 113 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.96969885 |
| 114 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.96969885 |
| 115 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.96969885 |
| 116 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96902414 |
| 117 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.96890846 |
| 118 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.93947664 |
| 119 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.91878512 |
| 120 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.91131626 |
| 121 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.90940751 |
| 122 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.89602361 |
| 123 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.89577311 |
| 124 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.89195832 |
| 125 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.88123156 |
| 126 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.88123156 |
| 127 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.88096992 |
| 128 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.87329748 |
| 129 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.87095592 |
| 130 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86444166 |
| 131 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.86399372 |
| 132 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.85631424 |
| 133 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.84945720 |
| 134 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.84936532 |
| 135 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.84823401 |
| 136 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.84433347 |
| 137 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.84141887 |
| 138 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.83852316 |
| 139 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.82972812 |
| 140 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.82837786 |
| 141 | SPI1_23127762_ChIP-Seq_K562_Human | 0.82382135 |
| 142 | CJUN_26792858_Chip-Seq_BT549_Human | 0.81973737 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.19594958 |
| 2 | MP0005360_urolithiasis | 4.00891232 |
| 3 | MP0002837_dystrophic_cardiac_calcinosis | 3.44331485 |
| 4 | MP0005365_abnormal_bile_salt | 3.41602748 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 3.31144941 |
| 6 | MP0003705_abnormal_hypodermis_morpholog | 3.04741589 |
| 7 | MP0005451_abnormal_body_composition | 3.00111173 |
| 8 | MP0003252_abnormal_bile_duct | 2.88217121 |
| 9 | MP0004233_abnormal_muscle_weight | 2.47014952 |
| 10 | MP0005409_darkened_coat_color | 2.46472776 |
| 11 | MP0008875_abnormal_xenobiotic_pharmacok | 2.40929805 |
| 12 | MP0004084_abnormal_cardiac_muscle | 2.38519501 |
| 13 | MP0004130_abnormal_muscle_cell | 2.37723968 |
| 14 | MP0003300_gastrointestinal_ulcer | 2.36063365 |
| 15 | MP0010234_abnormal_vibrissa_follicle | 2.27950057 |
| 16 | MP0002796_impaired_skin_barrier | 2.27638666 |
| 17 | MP0009840_abnormal_foam_cell | 2.15896138 |
| 18 | MP0010329_abnormal_lipoprotein_level | 2.09883320 |
| 19 | MP0003941_abnormal_skin_development | 2.09482868 |
| 20 | MP0005083_abnormal_biliary_tract | 2.05969704 |
| 21 | MP0001666_abnormal_nutrient_absorption | 2.05934558 |
| 22 | MP0003453_abnormal_keratinocyte_physiol | 1.96613912 |
| 23 | MP0004036_abnormal_muscle_relaxation | 1.94871821 |
| 24 | MP0003195_calcinosis | 1.93114890 |
| 25 | MP0002877_abnormal_melanocyte_morpholog | 1.87388296 |
| 26 | MP0000751_myopathy | 1.87008862 |
| 27 | MP0009780_abnormal_chondrocyte_physiolo | 1.86808997 |
| 28 | MP0008057_abnormal_DNA_replication | 1.82877112 |
| 29 | MP0005330_cardiomyopathy | 1.73830881 |
| 30 | MP0004087_abnormal_muscle_fiber | 1.72809525 |
| 31 | MP0003806_abnormal_nucleotide_metabolis | 1.70833018 |
| 32 | MP0003950_abnormal_plasma_membrane | 1.68888287 |
| 33 | MP0004185_abnormal_adipocyte_glucose | 1.68119985 |
| 34 | MP0005666_abnormal_adipose_tissue | 1.64523468 |
| 35 | MP0003191_abnormal_cellular_cholesterol | 1.59631060 |
| 36 | MP0002118_abnormal_lipid_homeostasis | 1.58824822 |
| 37 | MP0001730_embryonic_growth_arrest | 1.58617306 |
| 38 | MP0008438_abnormal_cutaneous_collagen | 1.58025135 |
| 39 | MP0010678_abnormal_skin_adnexa | 1.56850790 |
| 40 | MP0002060_abnormal_skin_morphology | 1.56641367 |
| 41 | MP0003566_abnormal_cell_adhesion | 1.51779279 |
| 42 | MP0008961_abnormal_basal_metabolism | 1.51761328 |
| 43 | MP0000609_abnormal_liver_physiology | 1.51265801 |
| 44 | MP0005332_abnormal_amino_acid | 1.51044381 |
| 45 | MP0004043_abnormal_pH_regulation | 1.49604389 |
| 46 | MP0010630_abnormal_cardiac_muscle | 1.47960556 |
| 47 | MP0005501_abnormal_skin_physiology | 1.45983795 |
| 48 | MP0005023_abnormal_wound_healing | 1.42430082 |
| 49 | MP0005375_adipose_tissue_phenotype | 1.41728444 |
| 50 | MP0000749_muscle_degeneration | 1.41558556 |
| 51 | MP0004215_abnormal_myocardial_fiber | 1.41353076 |
| 52 | MP0000747_muscle_weakness | 1.37896202 |
| 53 | MP0000678_abnormal_parathyroid_gland | 1.35033737 |
| 54 | MP0005319_abnormal_enzyme/_coenzyme | 1.33912406 |
| 55 | MP0000013_abnormal_adipose_tissue | 1.33212980 |
| 56 | MP0002269_muscular_atrophy | 1.31761070 |
| 57 | MP0004782_abnormal_surfactant_physiolog | 1.29768121 |
| 58 | MP0003646_muscle_fatigue | 1.29645917 |
| 59 | MP0010307_abnormal_tumor_latency | 1.28546489 |
| 60 | MP0000003_abnormal_adipose_tissue | 1.27916133 |
| 61 | MP0002909_abnormal_adrenal_gland | 1.27676186 |
| 62 | MP0001216_abnormal_epidermal_layer | 1.26488074 |
| 63 | MP0003693_abnormal_embryo_hatching | 1.26098673 |
| 64 | MP0009643_abnormal_urine_homeostasis | 1.25278399 |
| 65 | MP0008775_abnormal_heart_ventricle | 1.25155061 |
| 66 | MP0002972_abnormal_cardiac_muscle | 1.25100415 |
| 67 | MP0003868_abnormal_feces_composition | 1.23323112 |
| 68 | MP0002009_preneoplasia | 1.22671603 |
| 69 | MP0002086_abnormal_extraembryonic_tissu | 1.16405193 |
| 70 | MP0003984_embryonic_growth_retardation | 1.15603835 |
| 71 | MP0002078_abnormal_glucose_homeostasis | 1.15540241 |
| 72 | MP0005275_abnormal_skin_tensile | 1.14764638 |
| 73 | MP0005670_abnormal_white_adipose | 1.13940749 |
| 74 | MP0005257_abnormal_intraocular_pressure | 1.13671974 |
| 75 | MP0001544_abnormal_cardiovascular_syste | 1.13071730 |
| 76 | MP0005385_cardiovascular_system_phenoty | 1.13071730 |
| 77 | MP0001672_abnormal_embryogenesis/_devel | 1.13001710 |
| 78 | MP0005380_embryogenesis_phenotype | 1.13001710 |
| 79 | MP0006054_spinal_hemorrhage | 1.12912059 |
| 80 | MP0005620_abnormal_muscle_contractility | 1.11173446 |
| 81 | MP0002088_abnormal_embryonic_growth/wei | 1.10754611 |
| 82 | MP0003656_abnormal_erythrocyte_physiolo | 1.10293429 |
| 83 | MP0009672_abnormal_birth_weight | 1.10049344 |
| 84 | MP0002138_abnormal_hepatobiliary_system | 1.08521590 |
| 85 | MP0004957_abnormal_blastocyst_morpholog | 1.07371148 |
| 86 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.06860337 |
| 87 | MP0004808_abnormal_hematopoietic_stem | 1.06676038 |
| 88 | MP0004510_myositis | 1.05789875 |
| 89 | MP0000537_abnormal_urethra_morphology | 1.05638721 |
| 90 | MP0001915_intracranial_hemorrhage | 1.05622087 |
| 91 | MP0005621_abnormal_cell_physiology | 1.05019291 |
| 92 | MP0000377_abnormal_hair_follicle | 1.04183117 |
| 93 | MP0006138_congestive_heart_failure | 1.02996814 |
| 94 | MP0000350_abnormal_cell_proliferation | 1.02797367 |
| 95 | MP0000762_abnormal_tongue_morphology | 1.02340359 |
| 96 | MP0005058_abnormal_lysosome_morphology | 1.02147709 |
| 97 | MP0003045_fibrosis | 1.02029763 |
| 98 | MP0010352_gastrointestinal_tract_polyps | 1.01414767 |
| 99 | MP0003303_peritoneal_inflammation | 1.00201737 |
| 100 | MP0003890_abnormal_embryonic-extraembry | 0.99738003 |
| 101 | MP0000627_abnormal_mammary_gland | 0.97515096 |
| 102 | MP0002971_abnormal_brown_adipose | 0.97426496 |
| 103 | MP0002098_abnormal_vibrissa_morphology | 0.95975727 |
| 104 | MP0005076_abnormal_cell_differentiation | 0.94804260 |
| 105 | MP0002106_abnormal_muscle_physiology | 0.94489177 |
| 106 | MP0004272_abnormal_basement_membrane | 0.92844334 |
| 107 | MP0002896_abnormal_bone_mineralization | 0.92646816 |
| 108 | MP0000467_abnormal_esophagus_morphology | 0.91979226 |
| 109 | MP0003111_abnormal_nucleus_morphology | 0.91976385 |
| 110 | MP0002396_abnormal_hematopoietic_system | 0.91452280 |
| 111 | MP0001661_extended_life_span | 0.90778678 |
| 112 | MP0000604_amyloidosis | 0.90285264 |
| 113 | MP0002084_abnormal_developmental_patter | 0.90136473 |
| 114 | MP0000759_abnormal_skeletal_muscle | 0.90087869 |
| 115 | MP0004947_skin_inflammation | 0.89601161 |
| 116 | MP0001881_abnormal_mammary_gland | 0.89498307 |
| 117 | MP0001765_abnormal_ion_homeostasis | 0.89103402 |
| 118 | MP0003329_amyloid_beta_deposits | 0.88767660 |
| 119 | MP0002080_prenatal_lethality | 0.88518012 |
| 120 | MP0003221_abnormal_cardiomyocyte_apopto | 0.87317202 |
| 121 | MP0004264_abnormal_extraembryonic_tissu | 0.85597073 |
| 122 | MP0000750_abnormal_muscle_regeneration | 0.85576905 |
| 123 | MP0010368_abnormal_lymphatic_system | 0.85568747 |
| 124 | MP0001697_abnormal_embryo_size | 0.85011411 |
| 125 | MP0009053_abnormal_anal_canal | 0.83981333 |
| 126 | MP0002234_abnormal_pharynx_morphology | 0.83582746 |
| 127 | MP0004197_abnormal_fetal_growth/weight/ | 0.83365934 |
| 128 | MP0009384_cardiac_valve_regurgitation | 0.82430917 |
| 129 | MP0001944_abnormal_pancreas_morphology | 0.82186932 |
| 130 | MP0005220_abnormal_exocrine_pancreas | 0.82175342 |
| 131 | MP0005167_abnormal_blood-brain_barrier | 0.81930574 |
| 132 | MP0001756_abnormal_urination | 0.81549676 |
| 133 | MP0000733_abnormal_muscle_development | 0.81234264 |
| 134 | MP0004085_abnormal_heartbeat | 0.80731960 |
| 135 | MP0004145_abnormal_muscle_electrophysio | 0.79918291 |
| 136 | MP0005187_abnormal_penis_morphology | 0.78804149 |
| 137 | MP0000579_abnormal_nail_morphology | 0.78068159 |
| 138 | MP0000598_abnormal_liver_morphology | 0.77936660 |
| 139 | MP0005334_abnormal_fat_pad | 0.77602118 |
| 140 | MP0003077_abnormal_cell_cycle | 0.76794293 |
| 141 | MP0002089_abnormal_postnatal_growth/wei | 0.76609775 |
| 142 | MP0001849_ear_inflammation | 0.75646040 |
| 143 | MP0003283_abnormal_digestive_organ | 0.75645618 |
| 144 | MP0002928_abnormal_bile_duct | 0.75574367 |
| 145 | MP0005623_abnormal_meninges_morphology | 0.74766629 |
| 146 | MP0009931_abnormal_skin_appearance | 0.74011234 |
| 147 | MP0008260_abnormal_autophagy | 0.73966936 |
| 148 | MP0005369_muscle_phenotype | 0.73872257 |
| 149 | MP0003091_abnormal_cell_migration | 0.73480534 |
| 150 | MP0009703_decreased_birth_body | 0.73142566 |
| 151 | MP0003279_aneurysm | 0.72904353 |
| 152 | MP0000383_abnormal_hair_follicle | 0.71878904 |
| 153 | MP0002693_abnormal_pancreas_physiology | 0.71388014 |
| 154 | MP0002085_abnormal_embryonic_tissue | 0.70787191 |
| 155 | MP0004484_altered_response_of | 0.70190542 |
| 156 | MP0003959_abnormal_lean_body | 0.70002721 |
| 157 | MP0005535_abnormal_body_temperature | 0.68306376 |
| 158 | MP0002166_altered_tumor_susceptibility | 0.67876558 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypoglycemic coma (HP:0001325) | 4.07254800 |
| 2 | Deep venous thrombosis (HP:0002625) | 4.03712997 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 3.54892232 |
| 4 | Right ventricular cardiomyopathy (HP:0011663) | 3.51534772 |
| 5 | Xanthomatosis (HP:0000991) | 3.49453121 |
| 6 | Hyporeflexia of lower limbs (HP:0002600) | 3.49386943 |
| 7 | Ketoacidosis (HP:0001993) | 3.46024063 |
| 8 | Sudden death (HP:0001699) | 3.33636970 |
| 9 | Ketosis (HP:0001946) | 3.33591686 |
| 10 | Exercise-induced muscle cramps (HP:0003710) | 3.27236693 |
| 11 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.15446573 |
| 12 | Myoglobinuria (HP:0002913) | 3.08722023 |
| 13 | Abnormality of the common coagulation pathway (HP:0010990) | 3.01356399 |
| 14 | Exercise-induced myalgia (HP:0003738) | 2.98797034 |
| 15 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.94341481 |
| 16 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.91448084 |
| 17 | Hypoglycemic seizures (HP:0002173) | 2.85021033 |
| 18 | Flat acetabular roof (HP:0003180) | 2.82549400 |
| 19 | Ventricular tachycardia (HP:0004756) | 2.80228849 |
| 20 | Asymmetric septal hypertrophy (HP:0001670) | 2.76323551 |
| 21 | Muscle fiber splitting (HP:0003555) | 2.71340413 |
| 22 | Ankyloglossia (HP:0010296) | 2.70286055 |
| 23 | Increased connective tissue (HP:0009025) | 2.69320057 |
| 24 | Hyperlipoproteinemia (HP:0010980) | 2.68361630 |
| 25 | Complement deficiency (HP:0004431) | 2.66561542 |
| 26 | Hyperammonemia (HP:0001987) | 2.61633373 |
| 27 | Hyperglycemia (HP:0003074) | 2.60064049 |
| 28 | Difficulty running (HP:0009046) | 2.59642866 |
| 29 | Bundle branch block (HP:0011710) | 2.58234345 |
| 30 | Abnormality of the intrinsic pathway (HP:0010989) | 2.55674210 |
| 31 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.54144998 |
| 32 | Dysmetric saccades (HP:0000641) | 2.53460826 |
| 33 | Hypoalphalipoproteinemia (HP:0003233) | 2.52808425 |
| 34 | Skin nodule (HP:0200036) | 2.51059648 |
| 35 | Subaortic stenosis (HP:0001682) | 2.48970299 |
| 36 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.48970299 |
| 37 | Lymphangioma (HP:0100764) | 2.44370864 |
| 38 | Epidermoid cyst (HP:0200040) | 2.44243126 |
| 39 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.44108143 |
| 40 | Cerebral aneurysm (HP:0004944) | 2.42995532 |
| 41 | Premature rupture of membranes (HP:0001788) | 2.42805302 |
| 42 | Arterial tortuosity (HP:0005116) | 2.42709050 |
| 43 | Calf muscle hypertrophy (HP:0008981) | 2.36053754 |
| 44 | Vertebral arch anomaly (HP:0008438) | 2.35244800 |
| 45 | Advanced eruption of teeth (HP:0006288) | 2.29857871 |
| 46 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.28292279 |
| 47 | Hypolipoproteinemia (HP:0010981) | 2.27607751 |
| 48 | Hypobetalipoproteinemia (HP:0003563) | 2.24948180 |
| 49 | Vascular tortuosity (HP:0004948) | 2.24710807 |
| 50 | Gout (HP:0001997) | 2.24341381 |
| 51 | Osteolytic defects of the hand bones (HP:0009699) | 2.23633364 |
| 52 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.23633364 |
| 53 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.22857647 |
| 54 | Myocardial infarction (HP:0001658) | 2.22387733 |
| 55 | Aneurysm (HP:0002617) | 2.21749010 |
| 56 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.20939778 |
| 57 | Hyperglycinuria (HP:0003108) | 2.17991615 |
| 58 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.17215549 |
| 59 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.15572650 |
| 60 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.15572650 |
| 61 | Syncope (HP:0001279) | 2.14088681 |
| 62 | Abnormality of purine metabolism (HP:0004352) | 2.11056007 |
| 63 | Atrioventricular block (HP:0001678) | 2.10389452 |
| 64 | Papillary thyroid carcinoma (HP:0002895) | 2.10183943 |
| 65 | Spinal rigidity (HP:0003306) | 2.09670525 |
| 66 | Abnormality of glycine metabolism (HP:0010895) | 2.06415423 |
| 67 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.06415423 |
| 68 | Termporal pattern (HP:0011008) | 2.05949288 |
| 69 | Insidious onset (HP:0003587) | 2.05949288 |
| 70 | Type 1 muscle fiber predominance (HP:0003803) | 2.05337312 |
| 71 | Lipoatrophy (HP:0100578) | 2.05210119 |
| 72 | Abnormality of oral frenula (HP:0000190) | 2.05138158 |
| 73 | EMG: myopathic abnormalities (HP:0003458) | 2.04917304 |
| 74 | Distal upper limb amyotrophy (HP:0007149) | 2.03984878 |
| 75 | Upper limb amyotrophy (HP:0009129) | 2.03984878 |
| 76 | Short nail (HP:0001799) | 2.02420283 |
| 77 | Macroorchidism (HP:0000053) | 2.01471279 |
| 78 | Prolonged partial thromboplastin time (HP:0003645) | 2.01359552 |
| 79 | Distal lower limb amyotrophy (HP:0008944) | 2.00616597 |
| 80 | Late onset (HP:0003584) | 1.97969192 |
| 81 | Symptomatic seizures (HP:0011145) | 1.97006778 |
| 82 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.96935167 |
| 83 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.96566160 |
| 84 | Fat malabsorption (HP:0002630) | 1.95731257 |
| 85 | Shallow orbits (HP:0000586) | 1.94869483 |
| 86 | Thin bony cortex (HP:0002753) | 1.94125660 |
| 87 | Hyperacusis (HP:0010780) | 1.93156805 |
| 88 | Hamartoma of the eye (HP:0010568) | 1.93103797 |
| 89 | Heart block (HP:0012722) | 1.91546022 |
| 90 | Hepatocellular carcinoma (HP:0001402) | 1.91276952 |
| 91 | Abnormality of carpal bone ossification (HP:0006257) | 1.90376575 |
| 92 | Ventricular arrhythmia (HP:0004308) | 1.90268383 |
| 93 | Palpitations (HP:0001962) | 1.89645653 |
| 94 | Abnormality of the Achilles tendon (HP:0005109) | 1.89592095 |
| 95 | Abnormality of the calf musculature (HP:0001430) | 1.89399477 |
| 96 | Difficulty climbing stairs (HP:0003551) | 1.89353911 |
| 97 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.88678024 |
| 98 | Dilated cardiomyopathy (HP:0001644) | 1.88138352 |
| 99 | Increased variability in muscle fiber diameter (HP:0003557) | 1.88051705 |
| 100 | Back pain (HP:0003418) | 1.87919287 |
| 101 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.87903235 |
| 102 | Heterotopia (HP:0002282) | 1.87842738 |
| 103 | Rhabdomyolysis (HP:0003201) | 1.87037725 |
| 104 | Progressive external ophthalmoplegia (HP:0000590) | 1.86890146 |
| 105 | Esophageal varix (HP:0002040) | 1.86753221 |
| 106 | Abnormality of complement system (HP:0005339) | 1.86502498 |
| 107 | Distal lower limb muscle weakness (HP:0009053) | 1.86213433 |
| 108 | Broad metatarsal (HP:0001783) | 1.85933231 |
| 109 | Abnormality of the salivary glands (HP:0010286) | 1.85486108 |
| 110 | Hypercholesterolemia (HP:0003124) | 1.84008773 |
| 111 | Atrial fibrillation (HP:0005110) | 1.83477316 |
| 112 | Tetraparesis (HP:0002273) | 1.83199155 |
| 113 | Abnormal atrioventricular conduction (HP:0005150) | 1.82191313 |
| 114 | Conjunctival hamartoma (HP:0100780) | 1.82127012 |
| 115 | Nemaline bodies (HP:0003798) | 1.82122702 |
| 116 | Hand muscle atrophy (HP:0009130) | 1.81899376 |
| 117 | Abnormal gallbladder morphology (HP:0012437) | 1.81258253 |
| 118 | Hypoplastic ischia (HP:0003175) | 1.81094154 |
| 119 | Wormian bones (HP:0002645) | 1.80810415 |
| 120 | Conjugated hyperbilirubinemia (HP:0002908) | 1.80136559 |
| 121 | Lip pit (HP:0100267) | 1.79667633 |
| 122 | Long toe (HP:0010511) | 1.79620935 |
| 123 | Cholelithiasis (HP:0001081) | 1.79465504 |
| 124 | Cholecystitis (HP:0001082) | 1.79420656 |
| 125 | Abnormal gallbladder physiology (HP:0012438) | 1.79420656 |
| 126 | Muscle fiber inclusion bodies (HP:0100299) | 1.78503085 |
| 127 | Fragile skin (HP:0001030) | 1.78395794 |
| 128 | Hyperkalemia (HP:0002153) | 1.78176106 |
| 129 | Atrophic scars (HP:0001075) | 1.77980982 |
| 130 | Vertebral compression fractures (HP:0002953) | 1.77701989 |
| 131 | Abnormality of the ischium (HP:0003174) | 1.77541254 |
| 132 | Abnormality of the fingertips (HP:0001211) | 1.77513643 |
| 133 | Mitral stenosis (HP:0001718) | 1.76685162 |
| 134 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.76237488 |
| 135 | Mitral valve prolapse (HP:0001634) | 1.76232472 |
| 136 | Sparse lateral eyebrow (HP:0005338) | 1.75742166 |
| 137 | Protuberant abdomen (HP:0001538) | 1.75166318 |
| 138 | Cubitus valgus (HP:0002967) | 1.75105185 |
| 139 | Hemorrhage of the eye (HP:0011885) | 1.74276119 |
| 140 | Hyperbilirubinemia (HP:0002904) | 1.73088379 |
| 141 | Polycythemia (HP:0001901) | 1.73066001 |
| 142 | Neonatal death (HP:0003811) | 1.70979348 |
| 143 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.69977350 |
| 144 | Protrusio acetabuli (HP:0003179) | 1.69934639 |
| 145 | Turricephaly (HP:0000262) | 1.69605180 |
| 146 | Hyperglycinemia (HP:0002154) | 1.69510989 |
| 147 | Relative macrocephaly (HP:0004482) | 1.69410123 |
| 148 | Overgrowth (HP:0001548) | 1.69175949 |
| 149 | Abnormality of the gastric mucosa (HP:0004295) | 1.67077724 |
| 150 | Hammertoe (HP:0001765) | 1.66798050 |
| 151 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.66727611 |
| 152 | Abnormal ossification of hand bones (HP:0005921) | 1.65822250 |
| 153 | Abnormal foot bone ossification (HP:0010675) | 1.65505672 |
| 154 | Subacute progressive viral hepatitis (HP:0006572) | 1.64540116 |
| 155 | Asymmetry of the thorax (HP:0001555) | 1.64438423 |
| 156 | Obstructive sleep apnea (HP:0002870) | 1.63756477 |
| 157 | Achilles tendon contracture (HP:0001771) | 1.63251913 |
| 158 | Increased nuchal translucency (HP:0010880) | 1.61357003 |
| 159 | Disproportionate tall stature (HP:0001519) | 1.60387460 |
| 160 | Overlapping toe (HP:0001845) | 1.60068038 |
| 161 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.59766641 |
| 162 | Progressive hearing impairment (HP:0001730) | 1.59755554 |
| 163 | Deep philtrum (HP:0002002) | 1.59076148 |
| 164 | Trismus (HP:0000211) | 1.58458273 |
| 165 | Curly hair (HP:0002212) | 1.58276028 |
| 166 | Cerebral inclusion bodies (HP:0100314) | 1.57829228 |
| 167 | Abnormal tarsal ossification (HP:0008369) | 1.56742914 |
| 168 | Broad face (HP:0000283) | 1.56014296 |
| 169 | Breech presentation (HP:0001623) | 1.55051666 |
| 170 | Fatigue (HP:0012378) | 1.54856760 |
| 171 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.53392932 |
| 172 | Long palpebral fissure (HP:0000637) | 1.53314351 |
| 173 | Progressive muscle weakness (HP:0003323) | 1.51699592 |
| 174 | Natal tooth (HP:0000695) | 1.51625070 |
| 175 | Abnormality of the calcaneus (HP:0008364) | 1.51395044 |
| 176 | Blue sclerae (HP:0000592) | 1.51142528 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.28701061 |
| 2 | PKN2 | 3.58950420 |
| 3 | ERN1 | 3.27688954 |
| 4 | TTN | 3.25969744 |
| 5 | PRPF4B | 2.42099387 |
| 6 | SIK1 | 2.29412094 |
| 7 | LATS2 | 2.26914453 |
| 8 | RIPK1 | 2.25607703 |
| 9 | MAP3K13 | 2.21832536 |
| 10 | SMG1 | 2.19104968 |
| 11 | EPHA2 | 2.06035120 |
| 12 | EPHB1 | 2.05366395 |
| 13 | PTK6 | 2.04231303 |
| 14 | STK24 | 2.03576259 |
| 15 | TAOK3 | 2.01550771 |
| 16 | LATS1 | 1.94995706 |
| 17 | BCKDK | 1.89953547 |
| 18 | INSRR | 1.83902540 |
| 19 | MAP3K9 | 1.81610709 |
| 20 | DMPK | 1.77189661 |
| 21 | FGFR4 | 1.72350539 |
| 22 | FRK | 1.68576768 |
| 23 | MAP3K10 | 1.68266959 |
| 24 | PDGFRA | 1.61047400 |
| 25 | EEF2K | 1.61007161 |
| 26 | LMTK2 | 1.59791876 |
| 27 | IRAK3 | 1.55308832 |
| 28 | BRD4 | 1.52762955 |
| 29 | PNCK | 1.49964995 |
| 30 | PDK4 | 1.48633151 |
| 31 | PDK3 | 1.48633151 |
| 32 | PRKD3 | 1.38342707 |
| 33 | CAMK1G | 1.35588950 |
| 34 | CAMK1D | 1.34111355 |
| 35 | MAP3K7 | 1.33255747 |
| 36 | MAP3K2 | 1.33147939 |
| 37 | TSSK6 | 1.22334725 |
| 38 | TTK | 1.21533971 |
| 39 | AKT3 | 1.18921310 |
| 40 | JAK1 | 1.18262891 |
| 41 | PHKG2 | 1.17160217 |
| 42 | PHKG1 | 1.17160217 |
| 43 | EIF2AK1 | 1.16386057 |
| 44 | MAP3K14 | 1.15669947 |
| 45 | RET | 1.14168980 |
| 46 | PRKCH | 1.11853151 |
| 47 | PAK3 | 1.09091067 |
| 48 | FLT3 | 1.08936005 |
| 49 | WNK4 | 1.05722982 |
| 50 | KSR2 | 1.05706379 |
| 51 | ICK | 1.05074272 |
| 52 | FGFR2 | 1.04847488 |
| 53 | SCYL2 | 1.02973510 |
| 54 | ARAF | 1.01913647 |
| 55 | LRRK2 | 1.01346015 |
| 56 | PTK2 | 1.00049689 |
| 57 | OBSCN | 0.99162257 |
| 58 | FGFR3 | 0.93731815 |
| 59 | PDGFRB | 0.92971023 |
| 60 | PAK4 | 0.92261380 |
| 61 | MET | 0.91806262 |
| 62 | KSR1 | 0.89814790 |
| 63 | WNK1 | 0.88212924 |
| 64 | JAK2 | 0.86748781 |
| 65 | STK38L | 0.85927993 |
| 66 | CDK9 | 0.85511628 |
| 67 | MTOR | 0.84981905 |
| 68 | MELK | 0.84102786 |
| 69 | PDPK1 | 0.83453103 |
| 70 | CDK12 | 0.82105374 |
| 71 | MAP3K1 | 0.81818742 |
| 72 | EIF2AK3 | 0.81650833 |
| 73 | BMX | 0.80123022 |
| 74 | MAP3K8 | 0.79398591 |
| 75 | * PRKD1 | 0.78645008 |
| 76 | NTRK1 | 0.77125425 |
| 77 | MAP2K3 | 0.76094068 |
| 78 | RPS6KB2 | 0.75739833 |
| 79 | SGK3 | 0.73928903 |
| 80 | PDK1 | 0.73644231 |
| 81 | NEK6 | 0.72395221 |
| 82 | PRKAA2 | 0.70984355 |
| 83 | PRKAA1 | 0.70378107 |
| 84 | MOS | 0.70176956 |
| 85 | PDK2 | 0.70094700 |
| 86 | BRAF | 0.68692876 |
| 87 | RAF1 | 0.68511364 |
| 88 | TGFBR2 | 0.67465496 |
| 89 | ALK | 0.67123321 |
| 90 | TYK2 | 0.66836517 |
| 91 | PIK3CA | 0.66599907 |
| 92 | CAMKK1 | 0.65057643 |
| 93 | EPHA3 | 0.64978117 |
| 94 | CDK7 | 0.64890168 |
| 95 | CDC42BPA | 0.64728426 |
| 96 | HIPK2 | 0.62909047 |
| 97 | MAP3K3 | 0.62322725 |
| 98 | FER | 0.62005522 |
| 99 | TRPM7 | 0.61444218 |
| 100 | PAK2 | 0.58101044 |
| 101 | STK3 | 0.56442707 |
| 102 | STK38 | 0.56247659 |
| 103 | MAPK11 | 0.56156311 |
| 104 | TAOK1 | 0.55982797 |
| 105 | CHEK1 | 0.55437097 |
| 106 | MST1R | 0.53788106 |
| 107 | NEK9 | 0.53366299 |
| 108 | CDK6 | 0.51926464 |
| 109 | PIK3CG | 0.51525759 |
| 110 | YES1 | 0.51482009 |
| 111 | ERBB4 | 0.51243160 |
| 112 | MAP2K1 | 0.51171567 |
| 113 | NEK1 | 0.50785502 |
| 114 | AKT2 | 0.50776931 |
| 115 | GSK3A | 0.50731754 |
| 116 | STK39 | 0.49738563 |
| 117 | DDR2 | 0.48972355 |
| 118 | PAK6 | 0.47000715 |
| 119 | MYLK | 0.46127885 |
| 120 | STK10 | 0.44597593 |
| 121 | ITK | 0.44137399 |
| 122 | TAOK2 | 0.42829453 |
| 123 | ROCK1 | 0.40571847 |
| 124 | MARK2 | 0.39891360 |
| 125 | JAK3 | 0.39711853 |
| 126 | PTK2B | 0.39592149 |
| 127 | DYRK1B | 0.39375993 |
| 128 | CDK4 | 0.38529489 |
| 129 | MST4 | 0.38085859 |
| 130 | TBK1 | 0.37445072 |
| 131 | MAPK10 | 0.37360905 |
| 132 | MAPKAPK3 | 0.37053952 |
| 133 | CSK | 0.36685422 |
| 134 | STK11 | 0.36410783 |
| 135 | ILK | 0.35864138 |
| 136 | RPS6KA2 | 0.35827306 |
| 137 | PRKACG | 0.34557536 |
| 138 | MAP4K1 | 0.34431816 |
| 139 | RPS6KB1 | 0.34125449 |
| 140 | MAP3K6 | 0.30719404 |
| 141 | PASK | 0.28080676 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.69763093 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.07567654 |
| 3 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.55774053 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.35790072 |
| 5 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.32622834 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.22623097 |
| 7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.16725799 |
| 8 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.09800839 |
| 9 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.09658188 |
| 10 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.07600252 |
| 11 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.94540990 |
| 12 | Thyroid cancer_Homo sapiens_hsa05216 | 1.93299920 |
| 13 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.89132502 |
| 14 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.84072929 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.75795595 |
| 16 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.73076242 |
| 17 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.65302121 |
| 18 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.53112003 |
| 19 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.49845558 |
| 20 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.49812359 |
| 21 | Bile secretion_Homo sapiens_hsa04976 | 1.49218028 |
| 22 | Endometrial cancer_Homo sapiens_hsa05213 | 1.48470153 |
| 23 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.45481621 |
| 24 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.45095652 |
| 25 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.42647594 |
| 26 | Prostate cancer_Homo sapiens_hsa05215 | 1.41117563 |
| 27 | Insulin resistance_Homo sapiens_hsa04931 | 1.31643377 |
| 28 | Lysine degradation_Homo sapiens_hsa00310 | 1.30118686 |
| 29 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.29017992 |
| 30 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.27348077 |
| 31 | Carbon metabolism_Homo sapiens_hsa01200 | 1.24734616 |
| 32 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.20289269 |
| 33 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.19245803 |
| 34 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.19210343 |
| 35 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.18786764 |
| 36 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.17840724 |
| 37 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.16348071 |
| 38 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.16047879 |
| 39 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.15985018 |
| 40 | Bladder cancer_Homo sapiens_hsa05219 | 1.14989058 |
| 41 | ABC transporters_Homo sapiens_hsa02010 | 1.14234664 |
| 42 | Other glycan degradation_Homo sapiens_hsa00511 | 1.11108017 |
| 43 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.08850189 |
| 44 | Peroxisome_Homo sapiens_hsa04146 | 1.08427574 |
| 45 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.07237712 |
| 46 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.07046049 |
| 47 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.05920329 |
| 48 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.04343111 |
| 49 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.01441344 |
| 50 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.00625531 |
| 51 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.00574711 |
| 52 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.00468636 |
| 53 | Hepatitis C_Homo sapiens_hsa05160 | 0.98531507 |
| 54 | Glioma_Homo sapiens_hsa05214 | 0.97756152 |
| 55 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.97561480 |
| 56 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.95980523 |
| 57 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.95289447 |
| 58 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.93214203 |
| 59 | Histidine metabolism_Homo sapiens_hsa00340 | 0.88902926 |
| 60 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.88270978 |
| 61 | Circadian rhythm_Homo sapiens_hsa04710 | 0.87767233 |
| 62 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.86906104 |
| 63 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.86775344 |
| 64 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.86694597 |
| 65 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.86429226 |
| 66 | Tight junction_Homo sapiens_hsa04530 | 0.85804498 |
| 67 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.83425795 |
| 68 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.83115264 |
| 69 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.83019745 |
| 70 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.82331190 |
| 71 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.81389167 |
| 72 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.80187312 |
| 73 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.78187324 |
| 74 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.76973730 |
| 75 | Cell cycle_Homo sapiens_hsa04110 | 0.76837617 |
| 76 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.74738759 |
| 77 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.74398220 |
| 78 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.74394672 |
| 79 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.74168804 |
| 80 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.73883204 |
| 81 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.73117439 |
| 82 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.72286350 |
| 83 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.70234664 |
| 84 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.69562436 |
| 85 | Focal adhesion_Homo sapiens_hsa04510 | 0.69465133 |
| 86 | Colorectal cancer_Homo sapiens_hsa05210 | 0.69005404 |
| 87 | Amoebiasis_Homo sapiens_hsa05146 | 0.68367096 |
| 88 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.67545772 |
| 89 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.67072185 |
| 90 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.64678772 |
| 91 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.64274373 |
| 92 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.63802065 |
| 93 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.63787329 |
| 94 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.63405280 |
| 95 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.62722205 |
| 96 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.62704433 |
| 97 | Hepatitis B_Homo sapiens_hsa05161 | 0.62414337 |
| 98 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.62108856 |
| 99 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.60106175 |
| 100 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.58454214 |
| 101 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.58392482 |
| 102 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.56447201 |
| 103 | Influenza A_Homo sapiens_hsa05164 | 0.56405042 |
| 104 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.55993612 |
| 105 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.55636339 |
| 106 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.54262031 |
| 107 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.53040845 |
| 108 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.52160610 |
| 109 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.52122934 |
| 110 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.51010746 |
| 111 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.50734913 |
| 112 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.50453204 |
| 113 | Insulin secretion_Homo sapiens_hsa04911 | 0.49549514 |
| 114 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.49216668 |
| 115 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.49132100 |
| 116 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.49064439 |
| 117 | Long-term potentiation_Homo sapiens_hsa04720 | 0.48248525 |
| 118 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.47820448 |
| 119 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.47259300 |
| 120 | Prion diseases_Homo sapiens_hsa05020 | 0.46279855 |
| 121 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.45630621 |
| 122 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.45366346 |
| 123 | Adherens junction_Homo sapiens_hsa04520 | 0.43654919 |
| 124 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.42075837 |
| 125 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.41704910 |
| 126 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.41524990 |
| 127 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.40398896 |
| 128 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.38235508 |
| 129 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.38025621 |
| 130 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.37796554 |
| 131 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.37683443 |
| 132 | Galactose metabolism_Homo sapiens_hsa00052 | 0.37412013 |
| 133 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.37395052 |
| 134 | Retinol metabolism_Homo sapiens_hsa00830 | 0.36257739 |
| 135 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.34223554 |
| 136 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.33708468 |
| 137 | Viral myocarditis_Homo sapiens_hsa05416 | 0.33590513 |
| 138 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.33193025 |
| 139 | Platelet activation_Homo sapiens_hsa04611 | 0.32015844 |
| 140 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.30057583 |
| 141 | Lysosome_Homo sapiens_hsa04142 | 0.29896815 |
| 142 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.28526296 |
| 143 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.28466951 |
| 144 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.28433379 |
| 145 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.28388246 |
| 146 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.28230883 |

